Kanaka Sai Ram Padam

Kanaka Sai Ram Padam

Auto-generated profile, based on publicly available information

Kanaka Sai Ram Padam

Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, United States

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2021 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
PDF file
KPKanaka Sai Ram Padam
Kanaka Sai Ram Padam
DBDhanraj Salur Basavarajappa
Dhanraj Salur Basavarajappa
USU Sangeetha Shenoy
U Sangeetha Shenoy
SCSanjiban Chakrabarty
Sanjiban Chakrabarty
SKShama Prasada Kabekkodu
Shama Prasada Kabekkodu
RRRaghu Radhakrishnan
Raghu Radhakrishnan

1 January 2024 in Journal of Oral Biology and Craniofacial Research
Verified
Journal Article
Open access
SSSmitha Sammith Shetty
Smitha Sammith Shetty
Mohit SharmaMohit Sharma
Mohit Sharma
KPKanaka Sai Ram Padam
Kanaka Sai Ram Padam
AKAdarsh Kudva
Adarsh Kudva
PPPratik Patel
Pratik Patel
RRRaghu Radhakrishnan
Raghu Radhakrishnan
Oral submucous fibrosis (OSF) is a persistent oral mucosal condition that carries an elevated risk of undergoing malignant transformation. Our objective was to elucidate the involvement of epithelial-to-mesenchymal transition (EMT) in OSF and its progression to malignancy by studying a panel of EMT markers, thereby understanding the molecular mechanisms. An immunohistochemical analysis was done to detect the presence of E-cadherin, N-cadherin, pan-cytokeratin (PanCK), vimentin, α-SMA (alpha-smooth muscle actin), and CD44 in a total of 100 tissue samples. These samples comprised 40 cases of OSF, 20 cases of oral squamous cell carcinoma associated with OSF (OSFSCC), and 40 cases of oral squamous cell carcinoma (OSCC). A whole transcriptomic analysis was performed on a group of seven matched samples encompassing NOM, OSF, OSFSCC, and OSCC. We observed significantly decreased expression of E-cadherin and PanCK, while N-cadherin, vimentin, α-SMA, and CD44 showed significantly higher expression in OSFSCC and OSCC as compared to OSF, both at protein and RNA levels. CD44 expression was noticeably higher in OSFSCC (p < 0.001) than in OSCC. Downregulation of epithelial markers with concomitant upregulation of mesenchymal and stem cell markers suggests the potential role of EMT and stemness in accelerating the pathogenesis and malignant transformation of OSF. The high levels of CD44 expression seen in OSFSCC indicate a high propensity for aggressiveness and acquisition of stem-like characteristics by the cells undergoing EMT.

7 August 2022 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
DBDhanraj Salur Basavarajappa
Dhanraj Salur Basavarajappa
KPKanaka Sai Ram Padam
Kanaka Sai Ram Padam
Sanjiban ChakrabartySanjiban Chakrabarty
Sanjiban Chakrabarty
NKNaveena AN Kumar
Naveena AN Kumar
RRRaghu Radhakrishnan
Raghu Radhakrishnan

1 July 2021 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Verified
Journal Article
Closed access
KPKanaka Sai Ram Padam
Kanaka Sai Ram Padam
SCSanjiban Chakrabarty
Sanjiban Chakrabarty
SKShama Prasada Kabekkodu
Shama Prasada Kabekkodu
BPBobby Paul
Bobby Paul
KHKeith D Hunter
Keith D Hunter
RRRaghu Radhakrishnan
Raghu Radhakrishnan

14 May 2026 in Blood
Verified
Journal Article
Open access
PDF file
RKRamesh Kumar
Ramesh Kumar
LLLinke Li
Linke Li
SUSarah Urbut
Sarah Urbut
MUMesbah Uddin
Mesbah Uddin
ANAbhishek Niroula
Abhishek Niroula
RKReuben Kapur
Reuben Kapur
Clonal hematopoiesis of indeterminate potential (CHIP) is characterized by age-related somatic mutations in hematopoietic stem and progenitor cells (HSC/Ps) and is correlated with an increased risk of myeloid malignancies, elevated inflammatory pathways in circulating myeloid cells, higher all-cause mortality, chronic kidney disease, and cardiovascular disease. The pathophysiology of inflammatory bowel disease (IBD) is intrinsically linked to heightened inflammation. Nevertheless, the presence of CHIP in IBD and its role in the pathophysiology of IBD remains poorly elucidated. In the UK Biobank, CHIP was associated with an increased incidence of IBD. Females with CHIP had a 1.33-fold higher risk, which was further validated in the All of Us database (ßodds ratio, 1.29). For Crohn's disease, DNA methyltransferase 3A (DNMT3A) mutations conferred a 1.81-fold increased incidence in females compared with non-DNMT3A carriers, which rose to 2.09 for large clones (variant allele fraction of ≥10%). In contrast, for ulcerative colitis, TET2 large clones were significantly associated, and only among individuals aged <45 years. These associations were further identified using 2-sample Mendelian randomization. In a mouse model of CHIP-IBD, HSC/Ps with Dnmt3a mutation demonstrated significantly worse pathophysiology compared with controls, due, in part, to heightened expression of apurinic/apyrimidinic endonuclease 1 (APE1) in the bone marrow and colon. Treatment with the APE1/redox factor 1 inhibitor APX3330 ameliorated CHIP-IBD driven by the Dnmt3a mutation.

12 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
RRRaghu Radhakrishnan
Raghu Radhakrishnan
HCHannah L. Crane
Hannah L. Crane
MDMarc Daigneault
Marc Daigneault
KPKanaka Sai Ram Padam
Kanaka Sai Ram Padam
KHKeith D. Hunter
Keith D. Hunter
Loss of RARβ2 expression by promoter methylation is an early event in oral carcinogenesis. Understanding the mechanisms and consequences of RARβ loss may aid in understanding the disappointing results of retinoid chemoprevention trials. This study aimed to describe the effects of all-trans retinoic acid (ATRA) and the de-methylating agent 5-Aza-2′ deoxycytidine (5-AZA-CdR) on a panel of immortal potentially malignant oral lesion (PMOL) cell cultures. RARβ expression was assessed in PMOL tissues by immunohistochemistry. Cells were treated with ATRA ± 5-AZA-CdR, and the effects on the cell cycle and senescence were assessed. In PMOL tissues, RARβ expression was variable, but lower in biopsies which gave rise to immortal cell cultures. Treatment of iPMOL cells with ATRA resulted in little change in RARβ expression, but the addition of 5-AZA-CdR resulted in significant increases. The effects on the cell cycle and senescence were variable and may be related to 5-AZA-CdR, as this has wider effects on the cell cycle. Overall, the response of iPMOL cells to ATRA and 5-AZA-CdR treatment was variable and is dependent on several factors, including RARβ-promoter methylation. These findings may help to explain the lack of consistent effect of retinoids in PMOLs seen in chemoprevention trials.